American Journal of Clinical Nutrition, Vol 65, 508-511, Copyright © 1997 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Identification of biotin sulfone, bisnorbiotin methyl ketone, and tetranorbiotin-l-sulfoxide in human urine

J Zempleni, DB McCormick and DM Mock
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, USA.

In previous studies using the HPLC and avidin-binding assay, five unidentified avidin-binding substances were observed in human urine. The present study investigated the identity of these substances. Urine was collected before and after intravenous administration of 18.5 mumol biotin to healthy adults. Unknown substances 1 and 3 were initially identified as biotin sulfone and bisnorbiotin methyl ketone, respectively, by coelution with authentic standards on HPLC. Identities were confirmed by thin-layer chromatography and by derivatization with p-dimethyl-aminocinnamaldehyde. As expected for biotin metabolites, the urinary excretion of biotin sulfone and bisnorbiotin methyl ketone increased with biotin administration. The urinary excretion of biotin sulfone increased 21-fold from 0.2 nmol/h before to 4.2 nmol/h after administration; the excretion of bisnorbiotin methyl ketone increased 130-fold from 0.4 to 51.8 nmol/h. At presumed steady state in free- living subjects (n = 6), biotin sulfone and bisnorbiotin methyl ketone accounted for 3.6% and 7.9% of total biotin excretion, respectively. Traces of tetranorbiotin-l-sulfoxide were also identified by using thin- layer chromatography and derivatization with p- dimethylaminocinnamaldehyde. However, tetranorbiotin-l-sulfoxide was not detectable in urine by the HPLC and avidin-binding assay because this metabolite has weak avidin-binding affinity. We conclude that biotin sulfone and bisnorbiotin methyl ketone are present in measurable quantities in human urine; their quantitation should allow more accurate studies on human biotin metabolism and turnover.

This article has been cited by other articles:

				T. Watanabe, K.-I. Oguchi, S. Ebara, and T. Fukui Measurement of 3-Hydroxyisovaleric Acid in Urine of Biotin-Deficient Infants and Mice by HPLC J. Nutr., March 1, 2005; 135(3): 615 - 618. [Abstract] [Full Text] [PDF]

				T. E. Peterson, L. R. McDowell, R. J. McMahon, N. S. Wilkinson, O. Rosendo, W. M. Seymour, P. R. Henry, F. G. Martin, and J. K. Shearer Balance and serum concentration of biotin in sheep fed alfalfa meal-based diets with increasing level of concentrate J Anim Sci, April 1, 2004; 82(4): 1165 - 1169. [Abstract] [Full Text] [PDF]

				R. Rodriguez-Melendez, B. Lewis, R. J. McMahon, and J. Zempleni Diaminobiotin and Desthiobiotin Have Biotin-Like Activities in Jurkat Cells J. Nutr., May 1, 2003; 133(5): 1259 - 1264. [Abstract] [Full Text] [PDF]

				D. M Mock, C. L Henrich, N. Carnell, and N. I Mock Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1061 - 1068. [Abstract] [Full Text] [PDF]

				S. C. Rathman, B. Lewis, and R. J. McMahon Acute glucocorticoid treatment increases urinary biotin excretion and serum biotin Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E643 - E649. [Abstract] [Full Text] [PDF]

				D. M. Mock, J. O. Nyalala, and R. M. Raguseo A Direct Streptavidin-Binding Assay Does Not Accurately Quantitate Biotin in Human Urine J. Nutr., August 1, 2001; 131(8): 2208 - 2214. [Abstract] [Full Text] [PDF]

				D. B. McCormick A Trail of Research on Cofactors: An Odyssey with Friends J. Nutr., February 1, 2000; 130(2): 323 - 323. [Abstract] [Full Text]

				J. Zempleni and D. M. Mock Marginal Biotin Deficiency Is Teratogenic Experimental Biology and Medicine, January 1, 2000; 223(1): 14 - 21. [Abstract] [Full Text]

				J. Zempleni and D. M Mock Bioavailability of biotin given orally to humans in pharmacologic doses Am. J. Clinical Nutrition, March 1, 1999; 69(3): 504 - 508. [Abstract] [Full Text] [PDF]

				J. Zempleni and D. M. Mock Advanced Analysis of Biotin Metabolites in Body Fluids Allows a More Accurate Measurement of Biotin Bioavailability and Metabolism in Humans J. Nutr., February 1, 1999; 129(2): 494 - 494. [Abstract] [Full Text] [PDF]

				K.-S. Wang, N. I. Mock, and D. M. Mock Biotin Biotransformation to Bisnorbiotin Is Accelerated by Several Peroxisome Proliferators and Steroid Hormones in Rats J. Nutr., November 1, 1997; 127(11): 2212 - 2216. [Abstract] [Full Text]

				J. Zempleni, G. M. Green, A. W. Spannagel, and D. M. Mock Biliary Excretion of Biotin and Biotin Metabolites Is Quantitatively Minor in Rats and Pigs J. Nutr., August 1, 1997; 127(8): 1496 - 1500. [Abstract] [Full Text]